Evaxion biotech to host q1 2022 corporate update conference call & webcast on may 11

Copenhagen, denmark, april 29, 2022 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage biotechnology company specializing in the development of ai-driven immunotherapies, announced today that it will present its first-quarter 2022 financial results on may 11 at 8.30 a.m. edt.

EVAX Ratings Summary

Quant